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Available online 17 August 2016Growing evidence suggests that the clinical use of neural progenitor cells (NPCs) is hampered by heterogeneity,
poor neuronal yield and low survival rate. Recently, we reported that retrovirus-delivered human arginine decar-
boxylase (hADC) genes improve cell survival against oxidative insult in murine NPCs in vitro. This study investi-
gates whether the induced expression of hADC gene in mNPCs induces any signiﬁcant change in the cell fate
commitment. The evaluation of induced hADC gene function was assessed by knockdown of hADC gene using
speciﬁc siRNA. The hADC gene delivery triggered higher expression of N-CAM, cell adhesion molecule and
MAP-2, neuronal marker. However, the hADC gene knockdown showed downregulation of N-CAM and MAP-2
expression suggesting that hADC gene delivery favors cell fate commitment of mNPCs towards neuronal lineage.
Neurite outgrowthwas signiﬁcantly longer in the hADC infected cells. The neurotrophic signal, BDNF aided in the
neuronal commitment, differentiation, andmaturation of hADC-mNPCs through PI3K and ERK1/2 activation. The
induction of neuron-like differentiation is believed to be regulated by the expression of GSK-3β and Wnt/β-ca-
tenin signaling pathways. Our ﬁndings suggest that hADC gene delivery favors cell fate commitment of mNPCs
towards neuronal lineage, bring new advances in the ﬁeld of neurogenesis and cell therapy.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Neural stem cells (NSCs) are deﬁned by their ability to proliferate,
self-renew and retain the potential to differentiate into neuronal and
glial lineages [1–4]. They are responsible for early nervous system de-
velopment and postnatal nervous tissue regeneration and repair [5–7].
Under normal conditions, neurogenesis in the adult mammalian brain
is restricted to two discrete germinal centers: the subgranular layer of
the hippocampal dentate gyrus and the subventricular zones of the lat-
eral ventricles [3,8,9]. Studies on NSCs provide a unique model system
to understand basic mechanisms of neural differentiation, but also
lead to improved strategies for neural tissue repair and cell-based re-
placement therapies in the nervous system and have the potential to
ameliorate parkinson's disease, huntington's disease, stroke, and trau-
matic brain injury leading to partial functional recovery [10,11]. Al-
though studies using stem cells provide hope, it is necessary to, Yonsei University College of
epublic of Korea.
n@ccmb.res.in (K.K. Bokara),
), jelee@yuhs.ac (J.E. Lee).
. This is an open access article underunderstand how to direct and control differentiation of speciﬁc target
phenotypes required for replacement and repair in each disease, as
well as to improve survival and differentiation levels of stem cells
after transplantation [12,13]. Recently, several techniques have been
adopted to regulate the differentiation, cell cycling or apoptosis of
stem cells by over-expressing antioxidant genes such as ADC which
can synthesize agmatine [14–16]. Despite several technical and safety
problems, scientists have started to translate their basic scientiﬁc ﬁnd-
ings into therapies for untreatable diseases [17].
A complete understanding of neural stem cells requires the identiﬁ-
cation of molecules that determine the self-renewal and multi-potent
characteristics of these cells. Several signaling pathways such as leuke-
mia inhibitory factor (LIF), Wnt protein and bone morphogenetic pro-
teins (BMPs), CAMs and integrins have been demonstrated to play a
role in stem cell fate determination of growth and development [18–
20]. However, molecular mechanisms underlying regulation of stem
cell fate by these extracellular factors remain unknown.
BMPs aremembers of the TransformingGrowth Factor-Beta (TGF-β)
family that play various, sometimes distinct roles throughout the devel-
opment of the nervous system, often in a context and stage-dependent
manner [21]. In early embryogenesis, BMPs inhibit neuro-ectoderm for-
mation [22,23] whereas in late embryogenesis, BMPs promote thethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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execute their functions by binding to and activating BMP receptors I
and II [27]. The BMP-Smad1/5/8 pathway is a major pathways control-
ling neurogenesis [28,29]. BMP receptor I phosphorylates Smad1/5/8
at the C-terminal SXS motif. Smad1/5/8 then associate with Smad4,
move into the nucleus, and turn on BMP-target genes to initiate
neurogenesis.
BMP-regulated gene expression is controlled without dependence of
cell-type through direct Smad binding and in a cell-type-speciﬁc manner
via interaction with tissue-speciﬁc transcription factors. These Smad-de-
pendent transcriptional targets coupled to cross-talk between the BMP
and other signaling pathways likelymediate transcriptional programs as-
sociated with cell fate choices [29]. However, little is known about the
BMP target genes except inhibitor of DNA binding/differentiation-1 (Id-
1) that controls neurogenesis. BMP target gene, Id-1appears to mediate
the inhibitory effects of BMPs on neuronal differentiation at least in
mouse embryonic stem cells (ESC) [19]. Id-1 binds to pro-neuronal tran-
scription factors such as Mammalian achaete-schute Homolog 1 (Mash1)
to inhibit their function.Wnt signaling has long been implicated in neural
crest induction [30], and in differentiation of melanocytes from cultured
NSCs isolated from mouse neural tube [31]. Neural crest stem cells
(NCSCs) lacking theWnt signaling component,β-catenin, fail to generate
sensory neurons [32]. While embryos expressing a constitutively active
formofβ-catenin inNCSCs develop sensory neurons at the expense of vir-
tually all other neural crest derivatives [33].
Cell adhesion molecules (CAMs) are transmembrane proteins that
are responsible for mediating adhesion of cells to other cells and/or
the extracellular matrix via their extracellular domains, while their in-
tracellular domain interacts with the cytoskeleton. Thus, CAMs provide
a direct link between the extracellular growth/guiding cues and the in-
tracellular scaffold responsible for morphology and growth. Four sub-
classes of CAMs are expressed in the brain [34].
Neural cell adhesion molecule (N-CAM), a multifunctional regulator
for cell adhesion, intracellular signaling, and cytoskeletal dynamics [35–
37], is expressed on the surface of most neural cells and plays a major
role in the development of the nervous system. Stimulation of N-CAM
results in the phosphorylation of extracellular signal regulated kinase I
and II (ERKI/II). Integrins are αβ heterodimeric proteins with roles in
adhesion to the extracellular matrix (ECM) and in cell–cell interactions
[38]. They play important roles in mesoderm development, epithelial
morphogenesis, neural tube closure, anchorage to ECM basal lamina
and central nervous system development [39]. An important property
of integrins is their capacity to cross-talk with growth factor receptors
[40].
Agmatine synthesized by ADC is stored in neuronal cells, may have
physiological functions as a neuromodulator [41] and exhibits protec-
tive effects both in vivo and in vitro [42–45], suggesting that availability
of agmatine helps protection. A recent study report suggests that
agmatine treatment to subventricular zone neural stem cells increased
neurogenesis and suppressed gliogenesis through the regulation of
BMPs and Smad1/5/8 expression [46], driving research on exploring
the protective effects of the ADC gene [14,47,48].
This study for the ﬁrst time, investigates the effect of hADC gene de-
livery on the stemness and cell fate commitment in hADC-mNPCs. The
events were investigated by checking the expression levels of microtu-
bule-associated protein-2 (MAP-2) and glial ﬁbrillary acidic protein
(GFAP) expressions for cell fate commitment. The morphological
change induced by hADC gene delivery was investigated by checking
the expression levels of adhesion molecules, N-CAM and integrin. The
hADC-mNPCs showed modulation of brain-derived neurotrophic factor
(BDNF), phosphoinositide 3-kinase (PI3K) and ERK1/2 expressions. Fur-
thermore, the role ofWnt/β-catenin signaling pathwaywas explored by
checking glycogen synthase kinase3β (GSK-3β), BMP-7, BMP-4, Smad1/
5/8 and Id-1 protein expressions for the neuronal commitment of hADC-
mNPCs. The effects of the induced hADC gene functions were evaluated
by knocking down the ADC gene using speciﬁc siRNA.2. Materials and methods
2.1. Animals
Pregnant female ICR mice were used to obtain stage E14 embryos
(KOATECH, South Korea). The animal experiments were performed in
accordance with the Korean Food and Drug Administration (KFDA)
guidelines. Protocols were reviewed and approved by the Institutional
Animal Care and Use Committee (IACUC) of the Yonsei Laboratory Ani-
mal Research Center (YLARC) (Permit #: 10–114). All mice were main-
tained in the pathogen-free facility of the YLARC.
2.2. Mice neural progenitor cells (mNPCs)
mNPCs were cultured as previously described [14]. See Supplemen-
tal experimental procedures.
2.3. Infection of retrovirus containing human arginine decarboxylase genes
(hADC) into mNPCs
The hADC-pCMV SPORT6 plasmid (6.4 Kb, purchased from NIH)
containing the cDNAof ADC (1383bp fragment of hADC cDNA, GenBank
accession number AY325129) was ampliﬁed using hisADC speciﬁc
primers (Forward primer: 5ʹ-GAA TTC gtc gcc acc atg cac cat cac cat
cac atg gct ggc tac c-3ʹ, Reverse primer: 5ʹ-CTC GAG tga tgc tcg ctg ggg
t-3ʹ) for 35 cycles, consisting of an initial denaturation for 5 min at
95 °C followed by 1min at 95 °C, 1min at 50 °C and 1min 72 °C. Follow-
ing this step, a ﬁnal extension was carried out at 72 °C for 10 min. The
polymerase chain reaction (PCR) products were ligated to a recombi-
nant retroviral expression vector pLXSN (K1060, Clontech). The retrovi-
rus containing the hADC genes was infected into mNPCs as described
earlier [48]. The clones with the highest titer were selected and stored
at−70 °C until use.
2.4. Experimental design
1-week cultured mNPCs were infected with retrovirus containing
empty vector (vLXSN) or human arginine decarboxylase genes
(vhADC). After 24 h of incubation with vLXSN or vhADC, the medium
was replaced with neural stem cell basal medium containing the differ-
entiation supplement and mNPCs were maintained for another week.
mNPCs infected with vhADC (hADC-mNPCs), mNPCs infected with
vLXSN (LXSN-mNPCs) and retrovirus-non-infected control mNPCs
(control mNPCs) were used for the experiments.
2.5. siRNAassay
For siRNA inhibition studies, hADC-siRNAmNPCs was designed as
hADC-mNPCs transfected with validated hADC-siRNA (siRNA No.
1002652, Bioneer) and hADC-siRNA control mNPCs as hADC-mNPCs
transfected with negative control siRNA (SN-1002, Bioneer) using the
Lipofectamine protocol (Invitrogen) at 11 DIV. After siRNA transfection
for 72 h, the hADC-mNPCs were collected at 14 DIV for immunocyto-
chemistry and protein analysis.
2.6. High performance liquid chromatography (HPLC) analysis
The agmatine concentration in control mNPCs, LXSN-mNPCs, hADC-
mNPCs, hADC-siRNA control mNPCs, and hADC-siRNA mNPCs were
measured by HPLC as previously described [48]. See Supplemental ex-
perimental procedures.
2.7. Immunocytochemistry
The mNPCs in all the experimental groups (control mNPCs, LXSN-
mNPCs, hADC-mNPCs,hADC-siRNA control mNPCs, and hADC-siRNA
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ature followed by washing with PBS. They were blocked using blocking
solution for 1 h at room temperature. They were reacted with appropri-
ate primary antibodies overnight at 4 °C. They were incubated with ap-
propriate secondary antibodies conjugated with Fluorescein
isothiocyanate (FITC, 1:200, Chemicon) or Rhodamine (1: 200,
Chemicon) for 2 h at room temperature. Finally, the nuclei of mNPCs
were stained with 4ʹ,6-diamidino-2-phenylindole (DAPI, Vector). Im-
ages were obtained by LSM 700 Confocal microscopy (Zeiss, Germany).
2.8. Western blot analysis
Equal amounts of proteins (30 μg) were extracted from control
mNPCs, LXSN-mNPCs, hADC-mNPCs, hADC-siRNAcontrol mNPCs, and
hADC-siRNA mNPCs. Samples were subjected to electrophoresis on
10–12% SDS-polyacrylamide gels. Separated proteins were then
electro-transferred onto Immobilion-NC membrane (Millipore). The
membranes were blocked for 1 h at room temperature with 5%
skimmed milk in tris-buffered saline (TBS) containing 0.1% Tween-20.
The membranes were incubated overnight with appropriate primary
antibodies. After washing three times with TBS with Tween-20 (TBS-
T), blots were incubated with peroxidase-conjugated anti-mouse IgG
or anti-rabbit IgG secondary antibodies for 1 h at room temperature. Fi-
nally, the blots were rinsed and proteins were visualized using an en-
hanced chemiluminescent protein detection kit (Thermo) according to
the manufacturer's instructions. The densitometric measurements of
all the detected proteins were performed by Scion Image Analysis Soft-
ware (version 3.5). All western blots were represented as a mean of at
least 3 independent experiments.
2.9. Neurite outgrowth measurement using cell IQ
The mNPCs from all the experimental groups were cultured in
Neurobasalmedium (Gibco)with 2% B-27 supplement and 5mMgluta-
mine at 11DIV. To evaluate newly generated neurite projections, three
areaswere randomly selected in single culturewell andwere visualized
using a digital camera under a 20× objective. Morphological changes of
neurospheres were continuously monitored and the images were cap-
tured every 30 min for a period of 56 h with Cell-IQ (CM Technologies
Ltd., Finland). The data were collected from 4 to 8 different culture
wells in each experimental group. The extension of neurite projections
from the neurospheres was measured with Cell-IQ Imagen Standalone
(ver. 2.9.3) and analyzed using Cell-IQ Analyzer 4 Pro-Write software
(ver. AN4.2.1).
2.10. Statistical analysis
All data were reported asmean± SD except neurite length. Statisti-
cal analysis of the data was performed with one-way ANOVA with
Tukey HSD test using SPSS Statistics (version 12.0, IBM). Differences
were considered statistically signiﬁcant at P b 0.05.
3. Results
3.1. Overexpression of hADC inmNPCs synthesized agmatine endogenously
The hADC gene infection intomNPCswas carried out using retroviral
vector system. The expression of ADC protein was conﬁrmed in control
mNPCs, LXSN-mNPCs (empty vector transfected), hADC-mNPCs, hADC-
siRNAcontrol mNPCs (hADC-mNPCs with control siRNA), and hADC-
siRNA mNPCs (hADC-mNPCs with hADC-siRNA) by immunocytochem-
istry and western blotting (Figs. 1A&B). Immunocytochemistry showed
higher expression of ADC positive cells in hADC infected mNPCs com-
pared with hADC non-infected mNPCs (Fig. 1A). In parallel, western
blotting also showed higher expression of ADC protein in hADC-
mNPCs, while less expression of ADC protein was seen in control andLXSN-mNPCs. However, the hADC-siRNA treatment to hADC-mNPCs
blocked the ADC expression (Fig. 1B).
HPLC analysis showed that endogenous agmatine levels were signif-
icantly higher in hADC-mNPCs compared with control mNPCs and
LXSN-mNPCs. However the agmatine concentration was signiﬁcantly
decreased in the hADC-siRNA mNPCs compared to hADC-mNPCs and
hADC-siRNA control mNPCs (Fig. 1C). The results suggested that over-
expression of hADC genes inmNPCs resulted in higher level of agmatine,
whereas, agmatine levels were signiﬁcantly decreased with hADC-
siRNA treatment.
3.2. The hADC gene delivery to mNPCs induced the expression of cell adhe-
sion molecules, integrin and N-CAM
Integrins and N-CAMs are major groups of cell-surface receptors for
both ECM and cell-surfacemolecules. They are the primarymediators of
neural cell behavior on ECM components and control various cell func-
tions including survival [49], migration [50,51], neurite outgrowth [52],
and myelination [53]. In the present study, hADC-infected mNPCs
showed attachment to the culture plate and the cells apparentlymigrat-
ed outward from the periphery of the attached neurospheres. To ex-
plore this phenomenon, the expression pattern of cell adhesion
molecules, integrin and N-CAM were examined in control mNPCs,
LXSN-mNPCs, hADC-mNPCs, hADC-siRNA control mNPCs, and hADC-
siRNAmNPCs. Interestingly, immunoﬂuorescence staining and western
blotting showed higher expression of N-CAM in hADC-mNPCs com-
pared with control mNPCs and LXSN-mNPCs (Fig. 2), whereas the ex-
pressions of N-CAM and integrin in hADC-mNPCs were decreased
through hADC-siRNA treatment (Figs. 2B–D).
These results suggest that hADC gene delivery to mNPCs, induces
morphological differentiation of neurospheres through higher expres-
sion of cell adhesion molecules, integrin and N-CAM in hADC-mNPCs.
3.3. The hADC genes infection to mNPCs favors commitment of neural pro-
genitor cells to neuron earlier than glia in hADC-mNPCs
The cell fate commitment of neural progenitor cells was determined
by checking the expression patterns of neuronal speciﬁcmarker, MAP-2
and glial speciﬁc marker, GFAP by immunoﬂuorescence and western
blotting (Fig. 3). To deﬁne the effect of ADC gene transfection on the dif-
ferentiation of neural progenitor cells deﬁnitely, we didn't use coated
plate. Immunoﬂuorescence staining showed that the number of MAP-
2 positive cells was higher in the hADC-mNPCs compared with control
and mock vector infected mNPCs, while the GFAP expressions were
not clear in the all experimental groups. The hADC-siRNA treatment to
the hADC-mNPCs showed almost similar pattern to that of control and
LXSN-mNPCs (Fig. 3A). To substantiate these ﬁndings, western blotting
was performedwithMAP-2 andGFAP antibodies in all the experimental
groups. Densitometry analysis showed that MAP-2 expression was sig-
niﬁcantly increased, whereas the GFAP expression was signiﬁcantly de-
creased in hADC-mNPCs and hADC-siRNA control mNPCs compared
with control mNPCs, LXSN-mNPCs and hADC-siRNA mNPCs (Figs. 3B-
D).
3.4. The hADC gene delivery to mNPCs accelerated neurite outgrowth in
neuronal culture condition
The length of neurite was measured to ﬁnd out if hADC gene trans-
fection to mNPCs affected neurite outgrowth of mNPCs under neuronal
culture condition. Many cells migrated out from neurosphere in hADC-
mNPCs compared with the other groups (Fig. 4A). The neurite length
per cell was increased in hADC-mNPCs (32.44 ± 6.34 μm/cell at 56 h
under neuronal culture condition) compared to control mNPCs
(4.97 ± 0.29 μm/cell), LXSN-mNPCs (15.73 ± 5.32 μm/cell) and hADC-
siRNA mNPCs (10.80 ± 1.61 μm/cell, Fig. 4B).
Fig. 1. Conﬁrmation of hADC protein expression and increased endogenous concentration of agmatine in mNPCs. The expression of hADC protein was conﬁrmed in the control mNPCs,
LXSN, hADC, and hADC-siRNA by immunocytochemistry (A) and immunoblotting (B). The endogenous concentration of agmatine measured by HPLC was increased in hADC-mNPCs
and hADC-siRNA control mNPCs (C). Scale bar is 100 μm. *, P b 0.05 vs control mNPCs; #, P b 0.05 vs LXSN-mNPCs; $, P b 0.05 vs hADC-mNPCs.
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brain derived neurotrophic factor (BDNF) expression and initiated differen-
tiation of neurospheres through PI3K and ERK1/2 activation
BDNF is reported to inﬂuence hippocampal neurogenesis [54,55],
neuronal survival [56,57] and neuroplasticity [58] suggesting that
BDNF promotes neurogenesis. We, therefore, investigated the effect ofFig. 2. The retroviral infection of hADC genes to mNPCs stimulated attachment of neurospheres
results showed strong expressions of N-CAM in hADC-mNPCs and hADC-siRNA control mNPCs
Integrin and N-CAM exhibited signiﬁcant increase in hADC-mNPCs and hADC-siRNA control m
P b 0.05 vs LXSN-mNPCs; $, P b 0.05 vs hADC-mNPCs.hADC gene delivery on the expression of BDNF and the downstream
proteins, PI3K and ERK1/2 expressions. Western blotting displayed
that in hADC-mNPCs and hADC-siRNA control mNPCs, the expression
levels of BDNF, PI3K and ERK1/2 were signiﬁcantly increased compared
with Control mNPCs and LXSN-mNPCs (Fig. 5). However, ADC knock-
down signiﬁcantly decreased the expression levels of BDNF, PI3K and
ERK1/2 compared with hADC-mNPCs and hADC-siRNA control mNPCs.by secreting cell adhesion molecules, integrin and N-CAM. Immunocytochemical staining
compared to the other experimental groups (A). The immunoblotting and quantitation of
NPCs compared to the others (B-D). Scale bar is 100 μm. *, P b 0.05 vs control mNPCs; #,
Fig. 3. The cell fate of mNPCs was induced towards neurons earlier than glia by the infection of hADC genes. The cell fate commitment of mNPCs due to the delivery of hADC genes was
determined by immunocytochemistry (A) and immunoblotting (B) of MAP-2 as neuronal speciﬁc marker and GFAP as astrocyte speciﬁc marker. MAP-2 was expressed intensively in
hADC-mNPCs and hADC-siRNA control mNPCs. The reduced expressions of GFAP were in hADC-mNPCs and hADC-siRNA control mNPCs, and compared to the others in immunoblotting
(C-D). Scale bar is 100 μm. *, P b 0.05 vs control mNPCs; #, P b 0.05 vs LXSN-mNPCs; $, P b 0.05 vs hADC-mNPCs.
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through the recruitment of BMP-4&7, Smad1/5/8, and Id-1 protein expres-
sion for the neuronal commitment in hADC-mNPCs.
Several signaling pathways including Wnt/β-catenin signaling have
been demonstrated to play key role in stem cell determination and the
downstream proteins, BMPs interplay in regulating the cell fate choices
in mouse embryonic stem cells [59]. Western blotting showed that the
expressions of β-catenin and GSK-3β (Figs. 6A, C and D) as well as
BMP-7 and downstream signal, Smad1/5/8 (Figs. 6B, E and G) were in-
creased in hADC-mNPCs and hADC-siRNA control mNPCs. BMP-4 isFig. 4. The transfection of hADC genes accelerated neurite elongation inmNPCs.Many neurites o
three time points represented, A). The quantitative analysis exhibited that neurite lengthwas sig
for Control mNPCs)). Data were expressed as mean ± SE. *, P b 0.05 vs control mNPCs; #, P b 0known to be related to glial differentiation and Id-1was reported tome-
diate the inhibitory effects on neuronal differentiation.Western blotting
showed that the expressions of BMP-4 and Id-1were signiﬁcantly lower
in hADC-mNPCs and hADC-siRNA control mNPCs compared with other
experimental groups (Figs. 6B, F and H). The speciﬁcity of the hADC
gene function was evaluated by knocking down the hADC gene with
hADC-siRNA treatment. The expressions of Id-1 and BMP-4 in hADC-
siRNA mNPCs were similar to that in control mNPCs and LXSN-mNPCs
(Figs. 6F&H).
The overall results demonstrated that hADC gene delivery to mNPCs
directed cell fate commitment to early neurogenesis at the expense off hADC-mNPCswere shown to be elongated in serial images taken for a period of 56 h (only
niﬁcantly longer in hADC-mNPCs than the others (B, n=6–8 culturewells (4 culturewells
.05 vs LXSN-mNPCs; +, P b 0.05 vs hADC-siRNA mNPCs.
Fig. 5. The transfection of hADC genes to mNPCs triggered the secretion of BDNF and promoted PI3K and ERK1/2 activation. Immunoblotting of BDNF, PI3K and ERK1/2, and the
quantitation of protein expressions displayed that the delivery of hADC genes into mNPCs induced the expression of neurotrophic factor, BDNF (A&B) and activated the downstream
proteins, PI3K (A&C) and ERK1/2 (A&D) in hADC-mNPCs and hADC-siRNA control mNPCs. *, P b 0.05 vs control mNPCs; #, P b 0.05 vs LXSN-mNPCs; $, P b 0.05 vs hADC-mNPCs.
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pathway.
4. Discussion
The neurosphere culture system is widely used to propagate
multipotent CNS precursors, but their differentiation into neurons, as-
trocytes and oligodendrocytes is rather poor [60,61]. Further, neural
stem/precursor cells (NSPCs) have limited proliferative and neurogenic
potential, whichmay restrict their therapeutic application [62]. Investi-
gations to identify ways for directing stem cells towards a speciﬁc phe-
notype have focused on providing signals to the cells to recapitulate
normal development.MouseNSCswere directed towards dopaminergic
neuronal differentiation by over-expressing Ngn2 and Nurr1 genes [63,
64]. Following grafting, these cells areparticularly vulnerable and have
poor survival. Hence, studies are required to enhance neurogenic poten-
tial and cell survival of the stem cells to combat the pathological condi-
tions that prevail in the microenvironment of CNS diseases. Our earlier
investigations suggested that hADCinfection to mNPCs and NIH3T3 cell
line conferred protection against oxidative insult [14,48].
This present study intended to investigatewhether hADC gene deliv-
ery to mNPCs could induce modulation in stem cell fate and
characteristics.
The induced expression of hADCwas conﬁrmed by immunostaining
and western blotting (Fig. 1A&B). The over-expression of hADC genes
signiﬁcantly increased endogenous agmatine (Fig. 1C). Adherence of
cells is important for differentiation as well as for proliferation, migra-
tion, neurite outgrowth, and synaptogenesis [65]. The cell adhesion
molecules, integrin and N-CAM, play important roles in proliferation,
migration, and invasion in various cell types and also control cell-cell
contact and cell-matrix adhesion during angiogenesis and neurite out-
growth [66]. Integrins play a role in NSC maintenance [67] and ensurethe neuron–glial recognition that is essential for neuronal migration
during cortical development [50]. N-CAM induced intracellular signal-
ing pathways to induce the extension of neurites in neuronal cell lines
or primary neurons [68]. From this approach, a large amount of data
has emerged concerning N-CAM signaling in vitro. Another end point
of N-CAM-mediated signaling in neurons is neuroprotection [69]. Dur-
ing our culture conditions, the hADC gene delivery stimulated earlier
differentiation of neurospheres compared to control mNPCs and
LXSN-mNPCs. Since cell adhesionmolecules, N-CAM and integrinmedi-
ate the attachment of neurospheres and differentiation, the expressions
of N-CAM and integrin were checked in all experimental groupsusing
immunocytochemistry and western blotting (Fig. 2). Immunocyto-
chemistry (Fig. 2A) as well asquantitative analysis of western blotting
showed signiﬁcant increase of N-CAM and integrin expression in
hADC-mNPCs, suggesting that hADC gene transfection to mNPCs stimu-
lates differentiation of NPCs in neurospheres through secretion of
integrin and N-CAM. However, hADC knockdown group showed de-
creased expression of the cell adhesion molecules compared
withhADC-mNPCs (Figs. 2B-D).
Generally to differentiate NPCs, coated plate should be used, but we
used uncoated plate to clealy observe the effect of ADCgene infection on
the differentiation of neural progenitor cells in this study. Interestingly,
hADC gene delivery not only mediated early differentiation of
neurospheres but also induced cell fate commitment of the
neurospheres toeards neuronal lineage in vitro.
The cell fate of neurospheres in all the experimental groups was de-
termined by choosing the neuron speciﬁcmarker, MAP-2 and the astro-
cyte speciﬁc marker, GFAP in all the experimental groups using
immunoﬂuorescence and western blotting (Fig. 3). Immunoﬂuores-
cence and western blotting studies showed signiﬁcant increase in the
MAP-2 expression in hADC-mNPCs compared with control mNPCs and
LXSN-mNPCs (Figs. 3B–D). The hADC gene functions were attenuated
Fig. 6. The viral infection of hADC genes intomNPCs changed the protein expressions of β-catenin, GSK-3ß, BMPs, Smad1/5/8 and Id-1 related to neural differentiation. The protein levels of
β-catenin (A&C) and GSK-3ß (A&D) were signiﬁcantly increased in hADC-mNPCs and hADC-siRNA control. The BMP-7 (B&E) and Smad1/5/8 (B&G)were shown to be increased in hADC-
mNPCs and hADC-siRNA control mNPCs, but the BMP-4 (B&F) and Id-1 (B&H) were presented to be decreased in hADC-mNPCs and hADC-siRNA control mNPCs. *, P b 0.05 vs control
mNPCs; #, P b 0.05 vs LXSN-mNPCs; $, P b 0.05 vs hADC-mNPCs.
262 K.K. Bokara et al. / Stem Cell Research 17 (2016) 256–265in the hADC knockdown group, hADC-siRNA mNPCs. These results sug-
gest that hADC gene infection to mNPCs, directes the neurospheres
cell fate commitment towards neurons earlier than astrocytes in
hADC-mNPCs.
The neurotrophic factor BDNF is essential for proliferation, differen-
tiation and survival of neurons. Following its binding to the TRK-B re-
ceptor, several canonical pathways such as the ERK/MAP kinase PI3K/
AKT, CREB and JAK/STAT3 are activated [70]. BDNF also promotes syn-
aptic maturation and modulates synaptic plasticity, including long-
term potentiation (LTP) [71]. In cultured rat hippocampal neurons, itwas demonstrated that depending on the delivery of BDNF, distinctmo-
lecular pathways were induced and inﬂuenced cell survival, morpholo-
gy, and functions [72]. The PI3K/AKT signaling pathway, downstream of
neurotrophins, is essential for neuronal survival as well as for the devel-
opment of dendrites. Ras signals via both PI3K/AKT andMAPKpathways
co-operate to promote elongation and dendritic ﬁlopodia like protru-
sion in dissociated postnatal hippocampal CA1/CA3 neuronal cultures
[73]. Our microarray data (results not shown) revealed higher expres-
sion of BDNF gene in the hADC- infected NPCs. The data was validated
by western blotting. Quantitative analysis of western blotting suggests
263K.K. Bokara et al. / Stem Cell Research 17 (2016) 256–265that hADC-mNPCs showed signiﬁcant increase in the expression of
BDNF and the downstream signaling proteins, PI3K and ERK1/2 com-
pared to control mNPCs and LXSN-mNPCs (Fig. 5). However, hADCgene
knockdown group showed decreased expression of BDNF and its down-
stream proteins compared with hADC-mNPCs. The data suggest that in-
duced ADC gene delivery promotes the secretion of BDNF which might
contribute for the early neurogenesis in hADC-mNPCs.
The β-catenindependentWnt signaling pathway is also important in
the modulation of cell proliferation, cell survival, and embryo develop-
ment [74–76] and is also identiﬁed as a regulator of stem cell fate deter-
mination [77,78]. It was found that phosphorylation levels of c-Myc and
β-catenin (targets of GSK-3) were increased at later stages in develop-
ment (when progenitor proliferation subsides and neuronal differentia-
tion predominates) [79]. As c-Myc and β-catenin are pro-proliferation
factors, and their phosphorylation byGSK-3β leads to their degradation,
it is suggested that activation of GSK-3β promotes neuronal differentia-
tion [79]. This idea is supported by a study inwhichDisc1 knockdown in
neural progenitors caused premature neuronal differentiation at the ex-
pense of the size of the progenitor pool [80]. When GSK-3β signaling
was examined, the levels of phosphorylated β-catenin and tyrosine-
phosphorylated GSK-3βwere increased [80]. The activation of the
Wnt/β-catenin signaling could modulate the bone morphogenetic pro-
teins which could regulate stem cell differentiation [81].
BMPsare secreted proteins that play key roles inneural tube pattern-
ing, mesoderm differentiation [82], regulation of proliferation and dif-
ferentiation of many different cell types [83] in addition to formation
and development of the nervous system [84] and regulation of stem
cell fate commitment [29]. BMP-4, in particular, is known to participate
in the astrocytic differentiation of NSPCs [85,86]. The expression of
BMP-7 is known to increase after CNS injury in motor neurons and
might regulate differentiation of glial cells from neural progenitors
[87,88]. The expression of BMP-7 was also reported to induce neuronal
differentiation from progenitor cells [89].
There is evidence that BMPs also modulate their sub speciﬁcationof
peripherin-expressing neurons. In primary neural crest stem cells,
BMPs induce cholinergic neurons [90]. BMPs also play key roles in reg-
ulating fate choices during stem cell differentiation. For example,
BMPs direct mesenchymal stem cells to chondrogenic and osteogenic
cell lineages [91]. BMPs have also been shown to regulate fate choices
in neural crest stem cells [31]. Moreover, the discovery of a key role
for BMP in maintaining embryonic stem cell self-renewal [19] is consis-
tent with the notion that this family of secreted factors has broad roles
in regulating stem cell biology. Of interest, an important interplay also
seems to exist between Wnt signaling and other signal pathways,
such as those activated by BMPs during neural development [92–94].
BMP functions through receptor-mediated intracellular signaling and
subsequently inﬂuences target gene transcription by Smads [95]. Previ-
ous report suggested that the BMP signaling pathway networks with
Wnt signaling [96]. In corroboration of the earlier investigations sug-
gesting the wnt role in inducing neurogenesis, our western
blottingdisplayed that hADC-mNPCs showed increased pattern of neu-
ronal differentiation than astrogenesis throughWnt/β-catenin signaling
by the recruitment of BMP-4, BMP-7, ERK 1/2, Smad1/5/8 and Id-1 pro-
tein expression (Figs. 5&6). However, neurogenesis ceased in thehADC-
siRNAmNPCs (Fig. 3). In addition,measurement of neurite length in the
hADC gene infected and non-infected groups for 56 h using Cell-IQ ma-
chine suggested that the relative length of the neurites in the hADC-
mNPCs was longer than the hADC-non infected mNPCs (Fig. 4). Howev-
er, hADC knockdown group showed signiﬁcant decrease in the neurite
length (Fig. 4B). These results suggest that hADC gene delivery to
mNPCs favors cell commitment towards neurons earlier than astrocytes
and the neuronal differentaition in hADC-mNPCs could be mediated
through BDNF and β-catenin signaling.
Overall, our present study demonstrated that hADC gene delivery
stimulated the attachment of neurospheres via the cell adhesion mole-
cules. hADC gene infection induced neuronal differentiation earlier thanastrogenesis via GSK-3β andWnt/β-catenin signaling pathways. In
NSCs, the function of Smad1 elevation seems to promote neuronal dif-
ferentiation [97]. The link to BMP-Smad signaling and Id-1 expression
may also underlie other aspects of development modulated by hADC
gene transfer.
Author disclosure statement
No competing ﬁnancial interests exist.
Acknowledgements
Authors would like to thank Dr. T. Ramakrishna Murti for his valu-
able comments and linguistic corrections in the manuscript. Authors
would also like to thankD.I Biotech (Seoul, Korea) for support to analyze
neurite outgrowth. This work was supported by the National Research
Foundation of Korea (NRF) grant funded by the Korea government
(MEST) (NRF-2014R1A2A2A01006556 and NRF-2013R1A1A2062711),
and CSIR network project BSC 0115 (mIND) INDIA (BSC-0115).
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.scr.2016.08.009.
References
Weiss, S., van der Kooy, D., 1998. CNS stem cells: where's the biology (a.k.a. beef)?
J. Neurobiol. 36, 307–314.
Alvarez-Buylla, A., Temple, S., 1998. Stem cells in the developing and adult nervous sys-
tem. J. Neurobiol. 36, 105–110.
Gage, F.H., Kempermann, G., Palmer, T.D., Peterson, D.A., Ray, J., 1998. Multipotent pro-
genitor cells in the adult dentate gyrus. J. Neurobiol. 36, 249–266.
McKay, R., 1997. Stem cells in the central nervous system. Science 276, 66–71.
Falk, S., Sommer, L., 2009. Stage- and area-speciﬁc control of stem cells in the developing
nervous system. Curr. Opin. Genet. Dev. 19, 454–460.
Shen, Q., Qian, X., Capela, A., Temple, S., 1998. Stem cells in the embryonic cerebral cortex:
their role in histogenesis and patterning. J. Neurobiol. 36, 162–174.
Gaulden, J., Reiter, J.F., 2008. Neur-ons and neur-offs: regulators of neural induction in
vertebrate embryos and embryonic stem cells. Hum. Mol. Genet. 17, R60–R66.
Reynolds, B.A., Tetzlaff, W., Weiss, S., 1992. A multipotent EGF-responsive striatal embry-
onic progenitor cell produces neurons and astrocytes. J. Neurosci. 12, 4565–4574.
Richards, L.J., Kilpatrick, T.J., Bartlett, P.F., 1992. De novo generation of neuronal cells from
the adult mouse brain. Proc. Natl. Acad. Sci. U. S. A. 89, 8591–8595.
Bjorklund, A., Lindvall, O., 2000. Cell replacement therapies for central nervous system
disorders. Nat. Neurosci. 3, 537–544.
McBride, J.L., Behrstock, S.P., Chen, E.Y., Jakel, R.J., Siegel, I., Svendsen, C.N., Kordower, J.H.,
2004. Human neural stem cell transplants improve motor function in a rat model of
Huntington's disease. J. Comp. Neurol. 475, 211–219.
Ito, K., Hirao, A., Arai, F., Takubo, K., Matsuoka, S., Miyamoto, K., Ohmura, M., Naka, K.,
Hosokawa, K., Ikeda, Y., Suda, T., 2006. Reactive oxygen species act through p38
MAPK to limit the lifespan of hematopoietic stem cells. Nat. Med. 12, 446–451.
Sola, S., Aranha, M.M., Rodrigues, C.M., 2012. Driving apoptosis-relevant proteins toward
neural differentiation. Mol. Neurobiol. 46, 316–331.
Bokara, K.K., Kwon, K.H., Nho, Y., Lee, W.T., Park, K.A., Lee, J.E., 2011. Retroviral expression
of arginine decarboxylase attenuates oxidative burden in mouse cortical neural stem
cells. Stem Cells Dev. 20, 527–537.
Greenberger, J.S., Epperly, M.W., Gretton, J., Jefferson, M., Nie, S., Bernarding, M., Kagan, V.,
Guo, H.L., 2003. Radioprotective gene therapy. Curr. Gene Ther. 3, 183–195.
Niu, Y., Shen, H., Epperly, M., Zhang, X., Nie, S., Cao, S., Greenberger, J.S., 2005. Protection of
esophageal multi-lineage progenitors of squamous epithelium (stem cells) from ion-
izing irradiation by manganese superoxide dismutase-plasmid/liposome (MnSOD-
PL) gene therapy. In Vivo 19, 965–974.
Park, D.H., Eve, D.J., 2009. Regenerative medicine: advances in newmethods and technol-
ogies. Med. Sci. Monit. 15, Ra233–Ra251.
Matsuda, T., Nakamura, T., Nakao, K., Arai, T., Katsuki, M., Heike, T., Yokota, T., 1999. STAT3
activation is sufﬁcient to maintain an undifferentiated state of mouse embryonic
stem cells. EMBO J. 18, 4261–4269.
Ying, Q.L., Nichols, J., Chambers, I., Smith, A., 2003. BMP induction of id proteins sup-
presses differentiation and sustains embryonic stem cell self-renewal in collaboration
with STAT3. Cell 115, 281–292.
Sato, N., Meijer, L., Skaltsounis, L., Greengard, P., Brivanlou, A.H., 2004. Maintenance of
pluripotency in human and mouse embryonic stem cells through activation of Wnt
signaling by a pharmacological GSK-3-speciﬁc inhibitor. Nat. Med. 10, 55–63.
Hogan, B.L., 1996. Bone morphogenetic proteins: multifunctional regulators of vertebrate
development. Genes Dev. 10, 1580–1594.
Wilson, P.A., Hemmati-Brivanlou, A., 1995. Induction of epidermis and inhibition of neural
fate by bmp-4. Nature 376, 331–333.
264 K.K. Bokara et al. / Stem Cell Research 17 (2016) 256–265Hemmati-Brivanlou, A., Melton, D., 1997. Vertebrate embryonic cells will become nerve
cells unless told otherwise. Cell 88, 13–17.
Varley, J.E., Maxwell, G.D., 1996. BMP-2 and BMP-4, but not BMP-6, increase the number
of adrenergic cells which develop in quail trunk neural crest cultures. Exp. Neurol.
140, 84–94.
Gross, R.E., Mehler, M.F., Mabie, P.C., Zang, Z., Santschi, L., Kessler, J.A., 1996. Bone mor-
phogenetic proteins promote astroglial lineage commitment by mammalian
subventricular zone progenitor cells. Neuron 17, 595–606.
Li, W., Cogswell, C.A., LoTurco, J.J., 1998. Neuronal differentiation of precursors in the neo-
cortical ventricular zone is triggered by BMP. J. Neurosci. 18, 8853–8862.
Larabee, S.M., Coia, H., Jones, S., Cheung, E., Gallicano, G.I., 2015. miRNA-17 members that
target Bmpr2 inﬂuence signaling mechanisms important for embryonic stem cell dif-
ferentiation in vitro and gastrulation in embryos. Stem Cells Dev. 24, 354–371.
Chen, H.L., Panchision, D.M., 2007. Concise review: bone morphogenetic protein
pleiotropism in neural stem cells and their derivatives–alternative pathways, conver-
gent signals. Stem Cells 25, 63–68.
Varga, A.C., Wrana, J.L., 2005. The disparate role of BMP in stem cell biology. Oncogene 24,
5713–5721.
Schmidt, C., Patel, K., 2005. Wnts and the neural crest. Anat. Embryol. (Berl) 209,
349–355.
Shah, N.M., Groves, A.K., Anderson, D.J., 1996. Alternative neural crest cell fates are in-
structively promoted by TGFbeta superfamily members. Cell 85, 331–343.
Hari, L., Brault, V., Kleber, M., Lee, H.Y., Ille, F., Leimeroth, R., Paratore, C., Suter, U., Kemler,
R., Sommer, L., 2002. Lineage-speciﬁc requirements of beta-catenin in neural crest
development. J. Cell Biol. 159, 867–880.
Lee, H.Y., Kleber, M., Hari, L., Brault, V., Suter, U., Taketo, M.M., Kemler, R., Sommer, L.,
2004. Instructive role of Wnt/beta-catenin in sensory fate speciﬁcation in neural
crest stem cells. Science 303, 1020–1023.
Nollet, F., Kools, P., van Roy, F., 2000. Phylogenetic analysis of the cadherin superfamily al-
lows identiﬁcation of six major subfamilies besides several solitary members. J. Mol.
Biol. 299, 551–572.
Muller, D., Djebbara-Hannas, Z., Jourdain, P., Vutskits, L., Durbec, P., Rougon, G., Kiss, J.Z.,
2000. Brain-derived neurotrophic factor restores long-term potentiation in polysialic
acid-neural cell adhesion molecule-deﬁcient hippocampus. Proc. Natl. Acad. Sci. U. S.
A. 97, 4315–4320.
Vutskits, L., Djebbara-Hannas, Z., Zhang, H., Paccaud, J.P., Durbec, P., Rougon, G., Muller, D.,
Kiss, J.Z., 2001. PSA-NCAMmodulates BDNF-dependent survival and differentiation of
cortical neurons. Eur. J. Neurosci. 13, 1391–1402.
Paratcha, G., Ledda, F., Ibanez, C.F., 2003. The neural cell adhesion molecule NCAM is an
alternative signaling receptor for GDNF family ligands. Cell 113, 867–879.
Hynes, R.O., 2002. Integrins: bidirectional, allosteric signaling machines. Cell 110,
673–687.
De Arcangelis, A., Georges-Labouesse, E., 2000. Integrin and ECM functions: roles in verte-
brate development. Trends Genet. 16, 389–395.
Schwartz, M.A., Ginsberg, M.H., 2002. Networks and crosstalk: integrin signalling spreads.
Nat. Cell Biol. 4, E65–E68.
Goracke-Postle, C.J., Nguyen, H.O., Stone, L.S., Fairbanks, C.A., 2006. Release of tritiated
agmatine from spinal synaptosomes. Neuroreport 17, 13–17.
Lee, G.T., Ha, H., Lee, H.C., Cho, Y.D., 2003. Agmatine reduces hydrogen peroxide in
mesangial cells under high glucose conditions. J. Biochem. Mol. Biol. 36, 251–257.
Kim, J.H., Yenari, M.A., Giffard, R.G., Cho, S.W., Park, K.A., Lee, J.E., 2004. Agmatine reduces
infarct area in a mouse model of transient focal cerebral ischemia and protects cul-
tured neurons from ischemia-like injury. Exp. Neurol. 189, 122–130.
Wang, W.P., Iyo, A.H., Miguel-Hidalgo, J., Regunathan, S., Zhu, M.Y., 2006. Agmatine pro-
tects against cell damage induced by NMDA and glutamate in cultured hippocampal
neurons. Brain Res. 1084, 210–216.
Hong, S., Lee, J.E., Kim, C.Y., Seong, G.J., 2007. Agmatine protects retinal ganglion cells from
hypoxia-induced apoptosis in transformed rat retinal ganglion cell line. BMC
Neurosci. 8, 81.
Song, H.W., Kumar, B.K., Kim, S.H., Jeon, Y.H., Lee, Y.A., Lee, W.T., Park, K.A., Lee, J.E., 2011.
Agmatine enhances neurogenesis by increasing ERK1/2 expression, and suppresses
astrogenesis by decreasing BMP 2,4 and SMAD 1,5,8 expression in subventricular
zone neural stem cells. Life Sci. 89, 439–449.
Jung, H.J., Yang,M.Z., Kwon, K.H., Yenari, M.A., Choi, Y.J., Lee,W.T., Park, K.A., Lee, J.E., 2010.
Endogenous agmatine inhibits cerebral vascular matrix metalloproteinases expres-
sion by regulating activating transcription factor 3 and endothelial nitric oxide syn-
thesis. Curr. Neurovasc. Res. 7, 201–212.
Moon, S.U., Kwon, K.H., Kim, J.H., Bokara, K.K., Park, K.A., Lee, W.T., Lee, J.E., 2010. Recom-
binant hexahistidine arginine decarboxylase (hisADC) induced endogenous agmatine
synthesis during stress. Mol. Cell. Biochem. 345, 53–60.
Frost, E.E., Buttery, P.C.,Milner, R., ffrench-Constant, C., 1999. Integrinsmediate a neuronal
survival signal for oligodendrocytes. Curr. Biol. 9, 1251–1254.
Anton, E.S., Kreidberg, J.A., Rakic, P., 1999. Distinct functions of alpha3 and alpha(v)
integrin receptors in neuronal migration and laminar organization of the cerebral
cortex. Neuron 22, 277–289.
Jacques, T.S., Relvas, J.B., Nishimura, S., Pytela, R., Edwards, G.M., Streuli, C.H., ffrench-
Constant, C., 1998. Neural precursor cell chain migration and division are regulated
through different beta1 integrins. Development 125, 3167–3177.
Mercado, M.L., Nur-e-Kamal, A., Liu, H.Y., Gross, S.R., Movahed, R., Meiners, S., 2004.
Neurite outgrowth by the alternatively spliced region of human tenascin-C is mediat-
ed by neuronal alpha7beta1 integrin. J. Neurosci. 24, 238–247.
Relvas, J.B., Setzu, A., Baron, W., Buttery, P.C., LaFlamme, S.E., Franklin, R.J., ffrench-
Constant, C., 2001. Expression of dominant-negative and chimeric subunits reveals
an essential role for beta1 integrin during myelination. Curr. Biol. 11, 1039–1043.
Lee, J., Duan, W., Mattson, M.P., 2002. Evidence that brain-derived neurotrophic factor is
required for basal neurogenesis and mediates, in part, the enhancement ofneurogenesis by dietary restriction in the hippocampus of adult mice.
J. Neurochem. 82, 1367–1375.
Scharfman, H., Goodman, J., Macleod, A., Phani, S., Antonelli, C., Croll, S., 2005. Increased
neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in
adult rats. Exp. Neurol. 192, 348–356.
Ang, E.T., Wong, P.T., Moochhala, S., Ng, Y.K., 2003. Neuroprotection associated with run-
ning: is it a result of increased endogenous neurotrophic factors? Neuroscience 118,
335–345.
Branchi, I., D'Andrea, I., Sietzema, J., Fiore, M., Di Fausto, V., Aloe, L., Alleva, E., 2006. Early
social enrichment augments adult hippocampal BDNF levels and survival of BrdU-
positive cells while increasing anxiety- and “depression”-like behavior. J. Neurosci.
Res. 83, 965–973.
Ding, Q., Vaynman, S., Akhavan, M., Ying, Z., Gomez-Pinilla, F., 2006. Insulin-like growth
factor I interfaces with brain-derived neurotrophic factor-mediated synaptic plastic-
ity to modulate aspects of exercise-induced cognitive function. Neuroscience 140,
823–833.
Reiriz, J., Espejo, M., Ventura, F., Ambrosio, S., Alberch, J., 1999. Bone morphogenetic pro-
tein-2 promotes dissociated effects on the number and differentiation of cultured
ventral mesencephalic dopaminergic neurons. J. Neurobiol. 38, 161–170.
Herrera, D.G., Garcia-Verdugo, J.M., Alvarez-Buylla, A., 1999. Adult-derived neural precur-
sors transplanted into multiple regions in the adult brain. Ann. Neurol. 46, 867–877.
Song, H., Stevens, C.F., Gage, F.H., 2002. Astroglia induce neurogenesis from adult neural
stem cells. Nature 417, 39–44.
Anderson, L., Burnstein, R.M., He, X., Luce, R., Furlong, R., Foltynie, T., Sykacek, P., Menon,
D.K., Caldwell, M.A., 2007. Gene expression changes in long term expanded human
neural progenitor cells passaged by chopping lead to loss of neurogenic potential in
vivo. Exp. Neurol. 204, 512–524.
Cesnulevicius, K., Timmer, M., Wesemann, M., Thomas, T., Barkhausen, T., Grothe, C., 2006.
Nucleofection is the most efﬁcient nonviral transfection method for neuronal stem
cells derived from ventral mesencephali with no changes in cell composition or dopa-
minergic fate. Stem Cells 24, 2776–2791.
Andersson, E.K., Irvin, D.K., Ahlsio, J., Parmar, M., 2007. Ngn2 and Nurr1 act in synergy to
induce midbrain dopaminergic neurons from expanded neural stem and progenitor
cells. Exp. Cell Res. 313, 1172–1180.
Derycke, L.D., Bracke, M.E., 2004. N-cadherin in the spotlight of cell-cell adhesion, differ-
entiation, embryogenesis, invasion and signalling. Int. J. Dev. Biol. 48, 463–476.
Utton, M.A., Eickholt, B., Howell, F.V., Wallis, J., Doherty, P., 2001. Soluble N-cadherin stim-
ulates ﬁbroblast growth factor receptor dependent neurite outgrowth and N-
cadherin and the ﬁbroblast growth factor receptor co-cluster in cells. J. Neurochem.
76, 1421–1430.
Campos, L.S., Leone, D.P., Relvas, J.B., Brakebusch, C., Fassler, R., Suter, U., ffrench-Constant,
C., 2004. Beta1 integrins activate a MAPK signalling pathway in neural stem cells that
contributes to their maintenance. Development 131, 3433–3444.
Kohler, L.B., Soroka, V., Korshunova, I., Berezin, V., Bock, E., 2010. A peptide derived from a
trans-homophilic binding site in neural cell adhesion molecule induces neurite out-
growth and neuronal survival. J. Neurosci. Res. 88, 2165–2176.
Ditlevsen, D.K., Kohler, L.B., Pedersen, M.V., Risell, M., Kolkova, K., Meyer, M., Berezin, V.,
Bock, E., 2003. The role of phosphatidylinositol 3-kinase in neural cell adhesion mol-
ecule-mediated neuronal differentiation and survival. J. Neurochem. 84, 546–556.
Islam, O., Loo, T.X., Heese, K., 2009. Brain-derived neurotrophic factor (BDNF) has prolif-
erative effects on neural stem cells through the truncated TRK-B receptor, MAP ki-
nase, AKT, and STAT-3 signaling pathways. Curr. Neurovasc. Res. 6, 42–53.
Bibel, M., Barde, Y.A., 2000. Neurotrophins: key regulators of cell fate and cell shape in the
vertebrate nervous system. Genes Dev. 14, 2919–2937.
Ji, Y., Lu, Y., Yang, F., Shen, W., Tang, T.T., Feng, L., Duan, S., Lu, B., 2010. Acute and gradual
increases in BDNF concentration elicit distinct signaling and functions in neurons.
Nat. Neurosci. 13, 302–309.
Kumar, V., Zhang, M.X., Swank, M.W., Kunz, J., Wu, G.Y., 2005. Regulation of dendritic
morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways.
J. Neurosci. 25, 11288–11299.
Moon, R.T., Kohn, A.D., De Ferrari, G.V., Kaykas, A., 2004.WNT and beta-catenin signalling:
diseases and therapies. Nat. Rev. Genet. 5, 691–701.
Gordon, M.D., Nusse, R., 2006. Wnt signaling: multiple pathways, multiple receptors, and
multiple transcription factors. J. Biol. Chem. 281, 22429–22433.
Stadeli, R., Hoffmans, R., Basler, K., 2006. Transcription under the control of nuclear arm/
beta-catenin. Curr. Biol. 16, R378–R385.
Willert, K., Jones, K.A., 2006. Wnt signaling: is the party in the nucleus? Genes Dev. 20,
1394–1404.
Reya, T., Clevers, H., 2005. Wnt signalling in stem cells and cancer. Nature 434, 843–850.
Kim, W.Y., Wang, X., Wu, Y., Doble, B.W., Patel, S., Woodgett, J.R., Snider, W.D., 2009. GSK-
3 is a master regulator of neural progenitor homeostasis. Nat. Neurosci. 12,
1390–1397.
Mao, Y., Ge, X., Frank, C.L., Madison, J.M., Koehler, A.N., Doud, M.K., Tassa, C., Berry, E.M.,
Soda, T., Singh, K.K., Biechele, T., Petryshen, T.L., Moon, R.T., Haggarty, S.J., Tsai, L.H.,
2009. Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via
modulation of GSK3beta/beta-catenin signaling. Cell 136, 1017–1031.
Haegele, L., Ingold, B., Naumann, H., Tabatabai, G., Ledermann, B., Brandner, S., 2003. Wnt
signalling inhibits neural differentiation of embryonic stem cells by controlling bone
morphogenetic protein expression. Mol. Cell. Neurosci. 24, 696–708.
Attisano, L., Wrana, J.L., 2002. Signal transduction by the TGF-beta superfamily. Science
296, 1646–1647.
Massague, J., Chen, Y.G., 2000. Controlling TGF-beta signaling. Genes Dev. 14, 627–644.
Liu, A., Niswander, L.A., 2005. Bone morphogenetic protein signalling and vertebrate ner-
vous system development. Nat. Rev. Neurosci. 6, 945–954.
Fukuda, S., Taga, T., 2005. Cell fate determination regulated by a transcriptional signal net-
work in the developing mouse brain. Anat. Sci. Int. 80, 12–18.
265K.K. Bokara et al. / Stem Cell Research 17 (2016) 256–265Weible 2nd, M.W., Chan-Ling, T., 2007. Phenotypic characterization of neural stem cells
from human fetal spinal cord: synergistic effect of LIF and BMP4 to generate astro-
cytes. Glia 55, 1156–1168.
Chang, C.F., Lin, S.Z., Chiang, Y.H., Morales, M., Chou, J., Lein, P., Chen, H.L., Hoffer, B.J.,
Wang, Y., 2003. Intravenous administration of bonemorphogenetic protein-7 after is-
chemia improves motor function in stroke rats. Stroke 34, 558–564.
Harvey, B.K., Hoffer, B.J., Wang, Y., 2005. Stroke and TGF-beta proteins: glial cell line-de-
rived neurotrophic factor and bone morphogenetic protein. Pharmacol. Ther. 105,
113–125.
Reissmann, E., Ernsberger, U., Francis-West, P.H., Rueger, D., Brickell, P.M., Rohrer, H.,
1996. Involvement of bone morphogenetic protein-4 and bone morphogenetic pro-
tein-7 in the differentiation of the adrenergic phenotype in developing sympathetic
neurons. Development 122, 2079–2088.
Sela-Donenfeld, D., Kalcheim, C., 1999. Regulation of the onset of neural crest migration
by coordinated activity of BMP4 and Noggin in the dorsal neural tube. Development
126, 4749–4762.
Tiedemann, H., Asashima, M., Grunz, H., Knochel, W., 2001. Pluripotent cells (stem cells)
and their determination and differentiation in early vertebrate embryogenesis. De-
velop. Growth Differ. 43, 469–502.Murashov, A.K., Pak, E.S., Hendricks, W.A., Owensby, J.P., Sierpinski, P.L., Tatko, L.M.,
Fletcher, P.L., 2005. Directed differentiation of embryonic stem cells into dorsal inter-
neurons. FASEB J. 19, 252–254.
Wine-Lee, L., Ahn, K.J., Richardson, R.D., Mishina, Y., Lyons, K.M., Crenshaw 3rd, E.B., 2004.
Signaling through BMP type 1 receptors is required for development of interneuron
cell types in the dorsal spinal cord. Development 131, 5393–5403.
Raible, D.W., Ragland, J.W., 2005. ReiteratedWnt and BMP signals in neural crest develop-
ment. Semin. Cell Dev. Biol. 16, 673–682.
Chen, D., Zhao, M., Mundy, G.R., 2004. Bone morphogenetic proteins. Growth Factors 22,
233–241.
Pal, R., Khanna, A., 2006. Role of smad- and wnt-dependent pathways in embryonic car-
diac development. Stem Cells Dev. 15, 29–39.
Hegarty, S.V., O'Keeffe, G.W., Sullivan, A.M., 2013. BMP-Smad 1/5/8 signalling in the de-
velopment of the nervous system. Prog. Neurobiol. 109, 28–41.
